comparemela.com
Home
Live Updates
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chi
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chi
22nd Century (Nasdaq: XXII) Appoints Dr. Calvin Treat as Chief Scientific Officer
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Related Keywords
University Of Nebraska At Omaha ,
Nebraska ,
United States ,
America ,
Mei Kuo ,
Matt Kreps ,
Jamesa Mish ,
Century Group Inc ,
Century Group Deep Expertise In Plant ,
Communications Investor Relations ,
Linkedin ,
Twitter ,
Century Group ,
University Of Nebraska ,
Nasdaq ,
University Of Wisconsin ,
Company Annual Report On Form ,
Youtube ,
Monsanto ,
Darrow Associates Investor Relations ,
Further Enhances ,
Deep Expertise ,
Calvin Treat ,
Chief Scientific Officer ,
Roundup Ready ,
South America ,
North America ,
Agriculture Economics ,
Annual Report ,
Media Contact ,
Investor Relations ,
Technology ,
Science ,
Business ,
Globe Newswire ,